{"id":1215,"date":"2023-10-19T19:06:06","date_gmt":"2023-10-19T19:06:06","guid":{"rendered":"https:\/\/bcchrmicro.wpengine.com\/?page_id=1215"},"modified":"2026-05-14T18:51:33","modified_gmt":"2026-05-14T18:51:33","slug":"publications","status":"publish","type":"page","link":"https:\/\/www.bcchr.ca\/levingslab\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"
\n\t
\n\t
\n\t
\n\t
\n\t<\/span>\n\tLevings Lab<\/span><\/a><\/span>News<\/span><\/a><\/span><\/div>\n

Publications<\/h1><\/div>\n
\n\t
\n\t<\/figure>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n
\n\t
\n\t
\n\t

To view Dr. Megan Levings’ Bibliography click here<\/u><\/a><\/h4>

Selected publications<\/h2>

2021<\/h3>

Induction of stable human FOXP3+ Tregs by a parasite-derived TGF-\u03b2 mimic<\/a><\/strong>
Cook L., et al.<\/em> Induction of stable human FOXP3+ Tregs by a parasite-derived TGF-\u03b2 mimic. Immunol Cell Biol.<\/em> 2021 Sep;99(8):833-847. doi: 10.1111\/imcb.12475. Epub (2021). PubMed PMID: 33929751; PubMed Central PMCID: PMC8453874.<\/p>

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile<\/a><\/strong>
Toxin B<\/a><\/strong>
Cook L.,\u00a0et al.\u00a0<\/em>Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B.\u00a0Gastroenterology<\/em>. (2021);160(6):2155-2158.e4. doi: 10.1053\/j.gastro.2021.01.009. Epub 2021 Jan 11. PubMed PMID: 33444574.<\/p>

mRNA vaccines take on immune tolerance<\/a><\/strong>
Wardell C.M. & Levings M.K. mRNA vaccines take on immune tolerance. Nat Biotechnol<\/em>. (2021);39(4):419-421. doi: 10.1038\/s41587-021-00880-0. PubMed PMID: 33785909.<\/p>

Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B<\/a><\/strong>
Cook L., et al.<\/em> Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B. Gastroenterology<\/em>. (2021);160(4):1410-1413.e4. doi: 10.1053\/j.gastro.2020.11.043. Epub 2020 Nov 27. PubMed PMID: 33253683.<\/p>

Transduction of Human T Cell Subsets with Lentivirus<\/a><\/strong>
Fung V.C.W., Rosado-S\u00e1nchez I. & Levings M.K. Transduction of Human T Cell Subsets with Lentivirus. Methods Mol Biol<\/em>. (2021);2285:227-254. doi: 10.1007\/978-1-0716-1311-5_19. PubMed PMID: 33928557.<\/p>

Cross talk between human regulatory T cells and antigen-presenting cells: Lessons for clinical applications<\/a><\/strong>
Wardell C.M., MacDonald K.N., Levings M.K. & Cook L. Cross talk between human regulatory T cells and antigen-presenting cells: Lessons for clinical applications. Eur J Immunol<\/em>. (2021);51(1):27-38. doi: 10.1002\/eji.202048746. Epub 2020 Dec 23. Review. PubMed PMID: 33301176.<\/p>

A method for expansion and retroviral transduction of mouse regulatory T cells<\/a><\/strong>
Wu D., et al<\/em>. A method for expansion and retroviral transduction of mouse regulatory T cells. J Immunol Methods<\/em>. (2021);488:112931. doi: 10.1016\/j.jim.2020.112931. Epub 2020 Nov 20. PubMed PMID: 33221458.<\/p>

2020<\/h3>

Building a CAR-Treg: Going from the basic to the luxury model<\/a><\/strong>
Rosado-S\u00e1nchez I. & Levings M.K. Building a CAR-Treg: Going from the basic to the luxury model. Cell Immunol.<\/em> 2020 Dec;358:104220. doi: 10.1016\/j.cellimm.2020.104220. Epub (2020). Review. PubMed PMID: 33096321.<\/p>

Pharmacological inhibition of RORC2 enhances human Th17-Treg stability and function<\/a><\/strong>
Boardman D.A., et al<\/em>. Pharmacological inhibition of RORC2 enhances human Th17-Treg stability and function. Eur J Immunol.<\/em> 2020 Sep;50(9):1400-1411. doi: 10.1002\/eji.201948435. Epub (2020). PubMed PMID: 32388860.<\/p>

Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells<\/a><\/strong> 
Dawson, N. A. J. et al.<\/em> Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells. Sci. Transl. Med<\/em>. 12 (2020). doi:10.1126\/scitranslmed.aaz3866<\/p>

T reg-specific insulin receptor deletion prevents diet-induced and age-associated metabolic syndrome<\/a><\/strong> 
Wu, D. et al.<\/em> T reg-specific insulin receptor deletion prevents diet-induced and age-associated metabolic syndrome. J. Exp. Med<\/em>. 217 (2020). doi:10.1084\/jem.20191542<\/p>

T-Cell specificity matters in IBD: Impaired IL10 production revealed by OmpC-tetramers<\/strong><\/a> 
Cook, L. & Levings, M. K. T-cell specificity matters in IBD: Impaired IL10 production revealed by OmpC-tetramers. Cell. Mol. Gastroenterol. Hepatol<\/em>. 10, 647-648 (2020). doi:10.1016\/j.jcmgh.2020.06.007<\/p>

Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients<\/a><\/strong> 
Sicard, A. et al<\/em>. Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients. Am. J. Transplant<\/em>. 20, 1562-1573 (2020). doi:10.1111\/ajt.15787<\/p>

Pharmacological inhibition of RORC2 enhances human Th17-Treg stability and function<\/a><\/strong>
Boardman, D. A. et al.<\/em> Pharmacological inhibition of RORC2 enhances human Th17-Treg stability and function. Eur. J. Immunol<\/em>. (2020). doi:10.1002\/eji.201948435<\/p>

Ectopic germline recombination activity of the widely used Foxp3-YFP-Cre mouse: A case report<\/a><\/strong>
Wu, D., Huang, Q., Orban, P. C. & Levings, M. K. Ectopic germline recombination activity of the widely used Foxp3-YFP-Cre mouse: A case report. Immunology<\/em> 159, 231-241 (2020). doi:10.1111\/imm.13153<\/p>

Analysis of flagellin-specific adaptive immunity reveals links to dysbiosis in patients with inflammatory bowel disease<\/a><\/strong>
Cook, L. et al.<\/em> Analysis of flagellin-specific adaptive immunity reveals links to dysbiosis in patients with inflammatory bowel disease. Cell. Mol. Gastroenterol. Hepatol<\/em>. 9, 485-506 (2020). doi:10.1016\/j.jcmgh.2019.11.012<\/p>

2019<\/h3>

A composite immune signature parallels disease progression across T1D subjects<\/a><\/strong>
Speake, C. et al.<\/em> A composite immune signature parallels disease progression across T1D subjects. JCI Insight<\/em> 4 (2019). doi:10.1172\/jci.insight.126917<\/p>

Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol<\/a><\/strong>
MacDonald, K. N. et al.<\/em> Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol. Cytotherapy<\/em> 21, 1216-1233 (2019). doi:10.1016\/j.jcyt.2019.10.011<\/p>

Suppressive and gut-reparative functions of human type 1 T regulatory cells<\/a><\/strong>
Cook, L. et al.<\/em> Suppressive and gut-reparative functions of human type 1 T regulatory cells. Gastroenterology<\/em> 157, 1584-1598 (2019). doi:10.1053\/j.gastro.2019.09.002<\/p>

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)<\/a><\/strong>
Cossarizza, A. et al.<\/em> Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur. J. Immunol<\/em>. 49, 1457-1973 (2019). doi:10.1002\/eji.201970107<\/p>

Evaluating the role of Tregs in the progression of multiple myeloma<\/a><\/strong>
Lad, D. et al.<\/em> Evaluating the role of Tregs in the progression of multiple myeloma. Leuk. Lymphoma<\/em> 60, 2134-2142 (2019). doi:10.1080\/10428194.2019.1579324<\/p>

Methods to manufacture regulatory T cells for cell therapy<\/a><\/strong>
MacDonald, K. N., Piret, J. M. & Levings, M. K. Methods to manufacture regulatory T cells for cell therapy. Clin. Exp. Immunol<\/em>. 197, 52-63 (2019). doi:10.1111\/cei.13297<\/p>

A new mechanism of action in human and mouse Treg cells: The ke(y)to suppression<\/a><\/strong>
Wu, D. & Levings, M. K. A new mechanism of action in human and mouse Treg cells: The ke(y)to suppression. Immunity<\/em> 50, 1122-1124 (2019). doi:10.1016\/j.immuni.2019.04.008<\/p>

Innate control of tissue-reparative human regulatory T cells<\/a><\/strong>
Lam, A. J. et al.<\/em> Innate control of tissue-reparative human regulatory T cells. J. Immunol<\/em>. 202, 2195-2209 (2019). doi:10.4049\/jimmunol.1801330<\/p>

Cancer immunotherapies repurposed for use in autoimmunity<\/a><\/strong>
Boardman, D. A. & Levings, M. K. Cancer immunotherapies repurposed for use in autoimmunity. Nat. Biomed. Eng<\/em>. 3, 259-263 (2019). doi:10.1038\/s41551-019-0359-6<\/p>

Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells<\/a><\/strong>
Dawson, N. A. et al.<\/em> Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells. JCI Insight<\/em> 4 (2019). doi:10.1172\/jci.insight.123672 <\/p>

Treg gene signatures predict and measure type 1 diabetes trajectory<\/a><\/strong>
Pesenacker, A. M. et al.<\/em> Treg gene signatures predict and measure type 1 diabetes trajectory. JCI Insight<\/em> 4 (2019). doi:10.1172\/jci.insight.123879<\/p>

Characterization of regulatory T cells in obese omental adipose tissue in humans<\/a><\/strong>
Wu, D.\u00a0et al.<\/em>\u00a0Characterization of regulatory T cells in obese omental adipose tissue in humans.\u00a0Eur. J. Immunol.\u00a0<\/em>49, 336-347 (2019). doi:10.1002\/eji.201847570<\/p>

Innate control of tissue-reparative human regulatory T cells<\/a><\/strong>
Lam, A. J.\u00a0et al.<\/em>\u00a0Innate control of tissue-reparative human regulatory T cells.\u00a0J Immunol<\/em>. (2019). doi:10.4049\/jimmunol.1801330<\/p>

Methods to manufacture regulatory T cells for cell therapy<\/a><\/strong>
MacDonald, K. N., Piret,\u00a0J. M. & Levings, M. K. Methods to manufacture regulatory T cells for cell therapy.\u00a0Clin. Exp. Immunol<\/em>. (2019). doi:10.1111\/cei.13297<\/p>

Tailoring the homing capacity of human Tregs for directed migration to sites of Th1-inflammation or intestinal regions<\/a><\/strong>
Hoeppli, R. E.\u00a0et al.<\/em>\u00a0Tailoring the homing capacity of human Tregs for directed migration to sites of Th1-inflammation or intestinal regions.\u00a0Am. J. Transplant.\u00a0<\/em>19, 62-76\u00a0(2019). doi:10.1111\/ajt.14936<\/p>

Treg gene signatures predict and measure type 1 diabetes trajectory<\/a><\/strong>
Pesenacker, A. M.\u00a0et al.<\/em>\u00a0Treg gene signatures predict and measure type 1 diabetes trajectory.\u00a0JCI Insight\u00a0<\/em>4 (2019). doi:10.1172\/jci.insight.123879<\/p>

2018<\/h3>

Engineering therapeutic T cells to suppress alloimmune responses using TCRs, CARs, or BARs<\/a><\/strong>
Sicard, A., Levings,\u00a0M. K. & Scott, D. W. Engineering therapeutic T cells to suppress alloimmune responses using TCRs, CARs, or BARs.\u00a0Am. J. Transplant.\u00a0<\/em>18, 1305-1311\u00a0(2018). doi:10.1111\/ajt.14747<\/p>

Guiding regulatory T cells to the allograft<\/a><\/strong>
Lamarche, C. & Levings, M. K. Guiding regulatory T cells to the allograft.\u00a0Curr. Opin. Organ Transplant.\u00a0<\/em>23, 106-113\u00a0(2018). doi:10.1097\/MOT.0000000000000483<\/p>

An optimized method to measure human FOXP3+\u00a0regulatory T cells from multiple tissue types using mass cytometry<\/a><\/strong>
Dawson, N. A. J.\u00a0et al.<\/em>\u00a0An optimized method to measure human FOXP3+ regulatory T cells from multiple tissue types using mass cytometry.\u00a0Eur. J. Immunol.<\/em>\u00a048, 1415-1419\u00a0(2018). doi:10.1002\/eji.201747407<\/p>

Regulatory T-cells drive immune dysfunction in C<\/a>LL<\/a><\/strong>
Lad, D.\u00a0et al.<\/em>\u00a0Regulatory T-cells drive immune dysfunction in CLL.\u00a0Leuk. Lymphoma\u00a0<\/em>59, 486-489\u00a0(2018). doi:10.1080\/10428194.2017.1330475<\/p>

A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies<\/a><\/strong>
Ivison, S.\u00a0et al.<\/em>\u00a0A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies.\u00a0JCI Insight\u00a0<\/em>3 (2018). doi:10.1172\/jci.insight.121867<\/p>

Taking regulatory T-cell therapy one step further<\/a><\/strong>
Sicard, A., Boardman,\u00a0D. A. &\u00a0Levings,\u00a0M. K. Taking regulatory T-cell therapy one step further.\u00a0Curr. Opin. Organ Transplant.\u00a0<\/em>23, 509-515\u00a0(2018). doi:10.1097\/MOT.0000000000000566<\/p>

2017<\/h3>

Adipose-tissue regulatory T cells: Critical players in adipose-immune crosstalk<\/a><\/strong>
Becker, M., Levings,\u00a0M. K. &\u00a0Daniel, C. Adipose-tissue regulatory T cells: Critical players in adipose-immune crosstalk.\u00a0Eur. J. Immunol<\/em>. (2017). doi:10.1002\/eji.201646739<\/p>

Antigen-specific regulatory T cells: Are police CARs the answer<\/a><\/strong>?<\/strong><\/a>
Dawson, N. A. J. &\u00a0Levings, M. K. Antigen-specific regulatory T cells: Are police CARs the answer?\u00a0Transl. Res.<\/em>\u00a0187, 53-58\u00a0(2017). doi:10.1016\/j.trsl.2017.06.009.<\/p>

Biomarker-guided stratification of autoimmune patients for biologic therapy<\/a><\/strong>
Ivison, S., des Rosiers, C., Lesage, S., Rioux,\u00a0J. D. &\u00a0Levings, M. K. Biomarker-guided stratification of autoimmune patients for biologic therapy.\u00a0Curr. Opin. Immunol.\u00a0<\/em>49, 56-63 (2017). doi:10.1016\/j.coi.2017.09.006<\/p>

Cd56bright natural killer\u00a0regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: The Canadian Blood and Marrow Transplant Group\u00a0randomized 0601 study results<\/a><\/strong>
Kariminia, A.\u00a0et al.<\/em>\u00a0CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: The Canadian Blood and Marrow Transplant Group randomized 0601 study results.\u00a0Haematologica<\/em>\u00a0(2017). doi:10.3324\/haematol.2017.170928<\/p>

Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease<\/a><\/strong>
Cook, L.\u00a0et al.<\/em>\u00a0Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease.\u00a0Allergy Clin. Immunol<\/em>. (2017). doi:10.1016\/j.jaci.2017.02.015<\/p>

Effect of ex vivo-expanded recipient regulatory T cells on hematopoietic chimerism and kidney allograft tolerance across MHC barriers in cynomolgus macaques<\/a><\/strong>
Duran-Struuck, R.\u00a0et al.<\/em>\u00a0Effect of ex vivo-expanded recipient regulatory T cells on hematopoietic chimerism and kidney allograft tolerance across MHC barriers in cynomolgus macaques.\u00a0Transplantation\u00a0<\/em>101, 274-283\u00a0(2017). doi:10.1097\/TP.0000000000001559<\/p>

Engineered tolerance: Tailoring development, function, and antigen-specificity of regulatory T cells<\/a><\/strong>
Dawson, N. A. J., Vent-Schmidt,\u00a0J. &\u00a0Levings, M. K. Engineered tolerance: Tailoring development, function, and antigen-specificity of regulatory T cells.\u00a0Front. Immunol.\u00a0<\/em>8, 1460\u00a0(2017). doi:10.3389\/fimmu.2017.01460.<\/p>

Guidelines for the use of flow cytometry and cell sorting in immunological studies<\/a><\/strong>
Cossarizza, A.\u00a0et al.<\/em>\u00a0Guidelines for the use of flow cytometry and cell sorting in immunological studies.\u00a0Eur. J. Immunol.\u00a0<\/em>47, 1584-1797 (2017). doi:10.1002\/eji.201646632<\/p>

Harnessing advances in T regulatory cell biology for <\/a>cellular <\/a>t<\/a>herapy in transplantation<\/a><\/strong>
Lam, A. J., Hoeppli,\u00a0R. E. &\u00a0Levings, M. K. Harnessing advances in T regulatory cell biology for cellular therapy in transplantation.\u00a0Transplantation<\/em>\u00a0101, 2277-2287\u00a0(2017). doi:10.1097\/TP.0000000000001757<\/p>

The outstanding questions in transplantation: It’s about time…<\/a><\/strong>
Azzi, J.\u00a0et al.\u00a0<\/em>The outstanding questions in transplantation: It’s about time…\u00a0Am. J. Transplant<\/em>. (2017). doi:10.1111\/ajt.14450<\/p>

Thymic progenitors of TCR\u03b1\u03b2 + CD8\u03b1\u03b1 intestinal intraepithelial lymphocytes require RasGRP1 for development<\/a><\/strong>
Golec, D. P.\u00a0et al. Thymic progenitors of TCR\u03b1\u03b2 + CD8\u03b1\u03b1 intestinal intraepithelial lymphocytes require RasGRP1 for development.\u00a0J. Exp. Med.\u00a0<\/em>214, 2421-2435\u00a0(2017). doi:10.1084\/jem.20170844<\/p>

2016<\/h3>

Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor<\/a><\/strong>
MacDonald, K. G.\u00a0et al.<\/em>\u00a0Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.\u00a0J.\u00a0Clin. Invest.\u00a0<\/em>126, 1413-1424\u00a0(2016). doi:10.1172\/JCI82771<\/p>

Discarded human thymus is a novel source of stable and long-lived therapeutic regulatory T cells<\/a><\/strong>
Dijke, I. E.\u00a0et al.<\/em>\u00a0Discarded human thymus is a novel source of stable and long-lived therapeutic regulatory T cells.\u00a0Am. J. Transplant.\u00a0<\/em>16, 58-71\u00a0(2016). doi:10.1111\/ajt.13456<\/p>

Filgrastim-stimulated bone marrow compared with filgrastim-mobilized peripheral blood in myeloablative sibling allografting for patients with hematologic malignancies: A randomized Canadian Blood and Marrow Transplant Group study<\/a><\/strong>
Couban, S.\u00a0et al.<\/em>\u00a0Filgrastim-stimulated bone marrow compared with filgrastim-mobilized peripheral blood in myeloablative sibling allografting for patients with hematologic malignancies: A randomized Canadian Blood and Marrow Transplant Group study.\u00a0Biol. Blood Marrow Transplant.\u00a0<\/em>22, 1410-1415\u00a0(2016). doi:10.1016\/j.bbmt.2016.04.017<\/p>

Heterogeneity of chronic graft-versus-host disease biomarkers: Association with CXCL10 and CXCR3+ NK\u00a0Cells<\/a><\/strong>
Kariminia, A.\u00a0et al.<\/em>\u00a0Heterogeneity of chronic graft-versus-host disease biomarkers: Association with CXCL10 and CXCR3+ NK cells.\u00a0Blood\u00a0<\/em>127, 3082-3091\u00a0(2016). doi:10.1182\/blood-2015-09-668251<\/p>

How antigen specificity directs regulatory T-cell function: Self, foreign and engineered specificity<\/a><\/strong>
Hoeppli, R. E., MacDonald, K. G., Levings,\u00a0M. K. &\u00a0Cook, L.\u00a0HLA\u00a0<\/em>88, 3-13\u00a0(2016). doi:10.1111\/tan.12822<\/p>

Obesity-associated adipose tissue inflammation and transplantation<\/a><\/strong>
Wu, D., Dawson,\u00a0N. A. &\u00a0Levings, M. K. Obesity-associated adipose tissue inflammation and transplantation.\u00a0Am. J. Transplant.\u00a0<\/em>16, 743-750.\u00a0(2016). doi:10.1111\/ajt.13578<\/p>

A regulatory T-cell gene signature is a specific and sensitive biomarker to identify children with new-onset type 1 diabetes<\/a><\/strong>
Pesenacker, A. M.\u00a0et al.\u00a0<\/em>A regulatory T-cell gene signature is a specific and sensitive biomarker to identify children with new-onset type 1 diabetes.\u00a0Diabetes\u00a0<\/em>65, 1031-1039\u00a0(2016). doi:10.2337\/db15-0572<\/p>

The role of FOXP3 in autoimmunity<\/a><\/strong>
Pesenacker, A. M., Cook,\u00a0L. & Levings, M. K. The role of FOXP3 in autoimmunity.\u00a0Curr. Opin. Immunol.\u00a0<\/em>43, 16-23\u00a0(2016). doi:10.1016\/j.coi.2016.07.004<\/p>

T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression<\/a><\/strong>
Patterson, S. J.\u00a0et al.<\/em>\u00a0T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.\u00a0J. Clin. Invest.\u00a0<\/em>126, 1039-1051\u00a0(2016). doi:10.1172\/JCI83987<\/p><\/div>\n<\/div><\/div>\n\n\n

\n\t
\n\t
\n\t
\n\t

Contact Us<\/h2>

Contact us with your inquiries.<\/p>Contact<\/a><\/div>\n

\n\t
\n\t<\/figure>\n<\/div>\n<\/div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_lmt_disableupdate":"","_lmt_disable":"","inline_featured_image":false,"footnotes":"","fndry_alternate_title":"Alternate Title!"},"class_list":["post-1215","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/pages\/1215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/comments?post=1215"}],"version-history":[{"count":5,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/pages\/1215\/revisions"}],"predecessor-version":[{"id":2468,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/pages\/1215\/revisions\/2468"}],"wp:attachment":[{"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/media?parent=1215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}